Evidence map›Paper›PMID 25423885›Full record

ArticleNature communications2014

HSP90 regulates DNA repair via the interaction between XRCC1 and DNA polymerase β.

Qingming Fang, Burcu Inanc, Sandy Schamus, Xiao-hong Wang, Leizhen Wei, Ashley R Brown, David Svilar, Kelsey F Sugrue, Eva M Goellner, Xuemei Zeng and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Qingming Fang1] Department of Pharmacology &Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA [2] Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.
Burcu InancThe Netherlands Cancer Institute, Division of Biological Stress Response, Amsterdam 1006BE, The Netherlands.
Sandy SchamusHillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.
Xiao-hong WangHillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.
Leizhen Wei1] Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA [2] Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Ashley R BrownHillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.
David Svilar1] Department of Pharmacology &Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA [2] Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.
Kelsey F SugrueHillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.
Eva M Goellner1] Department of Pharmacology &Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA [2] Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.
Xuemei ZengBiomedical Mass Spectrometry Center, University of Pittsburgh Schools of the Health Sciences, Pittsburgh, Pennsylvania 15213, USA.
Nathan A Yates1] Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA [2] Biomedical Mass Spectrometry Center, University of Pittsburgh Schools of the Health Sciences, Pittsburgh, Pennsylvania 15213, USA [3] Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.
Li Lan1] Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA [2] Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Conchita Vens1] The Netherlands Cancer Institute, Division of Biological Stress Response, Amsterdam 1006BE, The Netherlands [2] The Netherlands Cancer Institute, Division of Radiotherapy, Amsterdam 1006BE, The Netherlands.
Robert W Sobol1] Department of Pharmacology &Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA [2] Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA [3] Department of Human Genetics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania 15213, USA.
UPMC Hillman Cancer Center · USUniversity of Pittsburgh · USThe Netherlands Cancer Institute · NL

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Novel approaches to enhance tumor cell cytotoxicity of alkylating agentsR01CA148629 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI SOBOL, ROBERT W · 2010 to 2021
$3.4M
DNA repair deficient cells for analysisR44GM087798 · NIGMS · TREVIGEN, INC. · PI GEORGE, JAY, SOBOL, ROBERT W · 2010 to 2011
$2.5M
DNA Repair-on-a-Chip: Spatially Encoded Microwell ArraysR44ES021116 · NIEHS · TREVIGEN, INC. · PI ENGELWARD, BEVIN P., GEORGE, JAY · 2013 to 2015
$1.5M
Transcriptional Signatures of Homologous Recombination Deficiency for Targeted ChR21ES022291 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SOBOL, ROBERT W · 2013 to 2014
$434k
CometChip: Enabling Translation of DNA Damage and Repair AssaysR21ES019498 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ENGELWARD, BEVIN P., SOBOL, ROBERT W · 2011 to 2012
$434k
DNA Repair-on-a-Chip: Spatially Encoded Microwell ArraysR43ES021116 · NIEHS · TREVIGEN, INC. · PI ENGELWARD, BEVIN P., GEORGE, JAY · 2011 to 2011
$319k
Discovery Tools for Chemotherapy Resistance to Cell Death.R43GM099213 · NIGMS · TREVIGEN, INC. · PI GEORGE, JAY, SOBOL, ROBERT W · 2012 to 2012
$217k
DNA repair deficient human cells for genomic variation analysisR43GM087798 · NIGMS · TREVIGEN, INC. · PI GEORGE, JAY, SOBOL, ROBERT W · 2009 to 2009
$200k
NCATS NIH HHS UL1 TR0000005NCATS NIH HHS UL1 TR000005NCATS NIH HHS UL1TR000005NCI NIH HHS CA047904NCI NIH HHS CA148629NCI NIH HHS P30 CA047904NCI NIH HHS R01 CA148629NCRR NIH HHS UL1 RR024153NCRR NIH HHS UL1-RR024153NIEHS NIH HHS ES019498NIEHS NIH HHS ES021116NIEHS NIH HHS ES022291NIEHS NIH HHS R21 ES019498NIEHS NIH HHS R21 ES022291NIEHS NIH HHS R43 ES021116NIEHS NIH HHS R44 ES021116NIGMS NIH HHS GM087798NIGMS NIH HHS GM099213NIGMS NIH HHS R43 GM087798NIGMS NIH HHS R43 GM099213NIGMS NIH HHS R44 GM087798
6 · The paper itself

Abstract

Cellular DNA repair processes are crucial to maintain genome stability and integrity. In DNA base excision repair, a tight heterodimer complex formed by DNA polymerase β (Polβ) and XRCC1 is thought to facilitate repair by recruiting Polβ to DNA damage sites. Here we show that disruption of the complex does not impact DNA damage response or DNA repair. Instead, the heterodimer formation is required to prevent ubiquitylation and degradation of Polβ. In contrast, the stability of the XRCC1 monomer is protected from CHIP-mediated ubiquitylation by interaction with the binding partner HSP90. In response to cellular proliferation and DNA damage, proteasome and HSP90-mediated regulation of Polβ and XRCC1 alters the DNA repair complex architecture. We propose that protein stability, mediated by DNA repair protein complex formation, functions as a regulatory mechanism for DNA repair pathway choice in the context of cell cycle progression and genome surveillance.

Indexed as

DNA RepairCell LineDNA-Binding ProteinsDNA DamageDNA Polymerase betaHSP90 Heat-Shock ProteinsHumansModels, MolecularProtein BindingX-ray Repair Cross Complementing Protein 1DNA-Binding ProteinsDNA Polymerase betaHSP90 Heat-Shock ProteinsX-ray Repair Cross Complementing Protein 1XRCC1 protein, human

Identifiers

PMID25423885
PMCPMC4246423
OpenAlexW2076700051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.